US 9206257
Human monoclonal antibodies specific for glypican-3 and use thereof
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 9206257 (Human monoclonal antibodies specific for glypican-3 and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K47/6813, A61K47/6829